Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC (HKMPY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HKMPY · as of Jun 9, 2026
Key Statistics
Explore Hikma Pharmaceuticals PLC Data
hkmpy stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hkmpy competitorsHKMPY
DNPUF
GZPHF
HLBBF
HLUBF
LVZPFStock Performance
Full HistoryAbout Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a global pharmaceutical company that specializes in the development, production, commercialization, and distribution of a wide array of generic, branded, and in-licensed m…
what is hikma pharmaceuticals plc · hkmpy stock overview · hikma pharmaceuticals plc company profile · who is hikma pharmaceuticals plc ceo · hkmpy OTC · hikma pharmaceuticals plc headquarters · hikma pharmaceuticals plc business segments
About Stock Overview & Key Data
Hikma Pharmaceuticals PLC (HKMPY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Feb 7, 2012. As of the latest trading session, HKMPY stock price is $39.08, with a market capitalization of $4.3B. The stock has returned -31.33% over the past 12 months and -6.80% year-to-date.
In fiscal year 2025, Hikma Pharmaceuticals PLC reported revenue of $3.4B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hikma Pharmaceuticals PLC (HKMPY) stock price is $39.08. The stock is traded on OTC under the ticker symbol HKMPY. The 52-week range is $31.80 – $56.91.